Low Absolute Eosinophil Count Predicts In-Hospital Mortality in Cirrhosis With Systemic Inflammatory Response

Varsha Wilson1, Kunnothara Kantan Velayudhan1, Harshavardhan Rao2

  • 1Internal Medicine, Amrita Institute of Medical Sciences and Research, Kochi, IND.

Cureus
|February 15, 2021
PubMed

Insights

Low eosinophil counts may predict mortality in cirrhotic patients with sepsis and systemic inflammatory response syndrome (SIRS). This inexpensive biomarker, alongside C-reactive protein (CRP) and total leukocyte count (TLC), aids in assessing outcomes.

Area of Science:

  • Internal Medicine
  • Hepatology
  • Critical Care Medicine

Background:

  • Chronic liver disease (CLD) or cirrhosis is a major cause of morbidity and mortality.
  • Traditional prognostic scores (CTP, MELD) may be unreliable for predicting short-term survival in cirrhotic patients with acute illness and SIRS.
  • Absolute eosinophil count (AEC) has shown potential in identifying patients at increased risk for sepsis-related mortality.

Purpose of the Study:

  • To evaluate the utility of Absolute Eosinophil Count (AEC) in predicting in-hospital mortality in cirrhotic patients with Systemic Inflammatory Response Syndrome (SIRS).
  • To identify independent predictors of mortality in this patient cohort.

Main Methods:

  • A cross-sectional study involving 100 cirrhotic patients with SIRS (aged 16-80 years) in a tertiary care hospital.
  • AEC was measured as part of automated complete blood counts.
  • Receiver operating characteristic (ROC) curve analysis and multivariate Cox regression were used to determine the predictive value of AEC and other parameters for mortality.

Main Results:

  • Sixteen percent (16%) of patients died during hospitalization.
  • ROC curve analysis identified an AEC cutoff of 198.5 cells/µL for predicting in-hospital mortality (AUC=0.716, sensitivity=75%, specificity=38.1%).
  • Multivariate analysis revealed age, CRP, total leukocyte count (TLC), and AEC as significant independent predictors of mortality.

Conclusions:

  • Eosinopenia (low AEC) can serve as a cost-effective early warning biomarker for adverse outcomes and in-hospital mortality in hospitalized cirrhotic patients with SIRS.
  • CRP and TLC may also contribute to predicting outcomes, both independently and in conjunction with AEC.